$75.01 +1.87 (2.557%) Incyte Corp - NASDAQ

Nov. 26, 2014 | 04:00 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
11/24/2014Daly James MEVP, Chief Commercial Officer-11,111$74.08-100.00%
11/24/2014Daly James MEVP, Chief Commercial Officer501$16.624.72%
11/24/2014Daly James MEVP, Chief Commercial Officer7,832$16.62281.93%
11/17/2014Levy Richard SEVP, Chief Drug Dev&Medical Of-12,000$69.97-39.73%
11/17/2014Levy Richard SEVP, Chief Drug Dev&Medical Of12,000$14.7265.92%
11/12/2014Huber Reid MEVP, Chief Scientific Officer2,900$5.4611.71%
11/12/2014Huber Reid MEVP, Chief Scientific Officer7,835$9.4146.27%
11/12/2014Huber Reid MEVP, Chief Scientific Officer7,225$3.1126.11%
11/06/2014FRIEDMAN PAUL ADirector-185,653$67.87-30.78%
11/06/2014FRIEDMAN PAUL ADirector29,166$13.345.08%
11/06/2014FRIEDMAN PAUL ADirector156,487$9.4137.48%
10/23/2014Daly James MEVP, Chief Commercial Officer-11,111$53.49-100.00%
10/23/2014Daly James MEVP, Chief Commercial Officer7,832$16.62281.93%
10/23/2014Levy Richard SEVP, Chief Drug Dev&Medical Of13,904$3.11323.27%
10/23/2014Daly James MEVP, Chief Commercial Officer501$16.624.72%
10/16/2014Levy Richard SEVP, Chief Drug Dev&Medical Of-8,000$49.03-65.04%
10/16/2014Levy Richard SEVP, Chief Drug Dev&Medical Of8,000$14.72186.00%
9/23/2014Daly James MEVP, Chief Commercial Officer7,832$16.62282.03%
9/23/2014Daly James MEVP, Chief Commercial Officer-11,111$47.65-100.00%
9/23/2014Daly James MEVP, Chief Commercial Officer502$16.624.73%
9/16/2014Levy Richard SEVP, Chief Drug Dev&Medical Of8,000$14.72186.00%
9/16/2014Levy Richard SEVP, Chief Drug Dev&Medical Of-8,000$47.58-65.04%
8/25/2014Daly James MEVP, Chief Commercial Officer-11,111$51.96-100.00%
8/25/2014Daly James MEVP, Chief Commercial Officer501$16.624.72%
8/25/2014Daly James MEVP, Chief Commercial Officer7,832$16.62281.93%
8/18/2014Levy Richard SEVP, Chief Drug Dev&Medical Of-8,000$51.97-65.04%
8/18/2014Levy Richard SEVP, Chief Drug Dev&Medical Of8,000$14.72186.00%
7/23/2014Daly James MEVP, Chief Commercial Officer501$16.624.72%
7/23/2014Daly James MEVP, Chief Commercial Officer-11,111$48.54-100.00%
7/23/2014Daly James MEVP, Chief Commercial Officer7,832$16.62281.93%
7/16/2014Levy Richard SEVP, Chief Drug Dev&Medical Of8,000$14.72186.00%
7/16/2014Levy Richard SEVP, Chief Drug Dev&Medical Of-8,000$48.15-65.04%
6/23/2014Daly James MEVP, Chief Commercial Officer-2,777$56.38-100.00%
6/23/2014Daly James MEVP, Chief Commercial Officer502$16.626.41%
6/23/2014Daly James MEVP, Chief Commercial Officer-8,334$55.92-100.00%
6/16/2014Levy Richard SEVP, Chief Drug Dev&Medical Of-8,000$53.88-65.04%
6/16/2014Levy Richard SEVP, Chief Drug Dev&Medical Of8,000$14.72186.00%
6/05/2014HASTINGS DAVID CChief Financial Officer23,966$9.41281.95%
6/05/2014HASTINGS DAVID CChief Financial Officer50,000$3.11154.01%
6/05/2014HASTINGS DAVID CChief Financial Officer50,000$5.4660.63%
6/05/2014HASTINGS DAVID CChief Financial Officer-123,966$52.81-93.58%
6/04/2014HASTINGS DAVID CChief Financial Officer6,500$17.7976.47%
6/04/2014HASTINGS DAVID CChief Financial Officer43,500$14.72290.00%
6/04/2014HASTINGS DAVID CChief Financial Officer7,500$13.3412.82%
6/04/2014HASTINGS DAVID CChief Financial Officer18,534$9.4128.08%
6/04/2014HASTINGS DAVID CChief Financial Officer-76,034$52.61-89.94%
5/23/2014Daly James MEVP, Chief Commercial Officer-11,111$48.48-100.00%
5/23/2014Daly James MEVP, Chief Commercial Officer501$16.624.72%
5/23/2014Daly James MEVP, Chief Commercial Officer7,832$16.62281.93%
5/21/2014BAKER JULIANSenior Executive Officer10,000$7.022.63%
5/16/2014Levy Richard SEVP, Chief Drug Dev&Medical Of8,000$14.72186.00%
5/16/2014Levy Richard SEVP, Chief Drug Dev&Medical Of-8,000$50.68-65.04%
5/12/2014Chardonnet LaurentN/A-2,058$54.00-54.00%
5/02/2014Chardonnet LaurentN/A-34,000$51.55-89.92%
5/02/2014Chardonnet LaurentN/A19,406$9.41105.44%
5/02/2014Chardonnet LaurentN/A14,594$9.41382.94%
4/28/2014BROOKE PAUL ADirector25,000$7.0222.73%
4/23/2014Daly James MEVP, Chief Commercial Officer23,496$16.62422.97%
4/23/2014Daly James MEVP, Chief Commercial Officer-30,555$47.71-100.00%
4/23/2014Daly James MEVP, Chief Commercial Officer1,504$16.625.18%
2/20/2014FRIEDMAN PAUL ADirector33,354$3.117.99%
2/20/2014FRIEDMAN PAUL ADirector-33,354$63.51-7.40%
2/19/2014DE SCHUTTER RICHARD USenior Executive Officer7,455$8.884.81%
2/19/2014DE SCHUTTER RICHARD USenior Executive Officer-7,455$65.50-4.59%
2/19/2014FRIEDMAN PAUL ADirector40,919$3.119.80%
2/19/2014FRIEDMAN PAUL ADirector-40,919$62.66-8.93%
2/18/2014HASTINGS DAVID CChief Financial Officer-32,001$65.64-79.01%
2/18/2014DE SCHUTTER RICHARD USenior Executive Officer42,545$8.8827.45%
2/18/2014DE SCHUTTER RICHARD USenior Executive Officer-42,545$65.54-21.54%
2/18/2014FRIEDMAN PAUL ADirector181,426$11.9843.45%
2/18/2014FRIEDMAN PAUL ADirector39,166$8.996.54%
2/18/2014FRIEDMAN PAUL ADirector193,520$8.9930.33%
2/18/2014FRIEDMAN PAUL ADirector185,753$5.4622.34%
2/18/2014FRIEDMAN PAUL ADirector120,171$3.1111.81%
2/18/2014FRIEDMAN PAUL ADirector-720,036$65.82-63.30%
2/18/2014HASTINGS DAVID CChief Financial Officer32,001$8.99376.48%
2/14/2014Levy Richard SEVP, Chief Drug Dev&Medical Of14,583$13.3450.13%
2/14/2014Levy Richard SEVP, Chief Drug Dev&Medical Of-39,787$66.13-90.24%
2/14/2014Levy Richard SEVP, Chief Drug Dev&Medical Of417$13.340.95%
2/14/2014Levy Richard SEVP, Chief Drug Dev&Medical Of24,787$9.41576.31%
2/14/2014HASTINGS DAVID CChief Financial Officer-40,000$64.74-82.47%
2/14/2014HASTINGS DAVID CChief Financial Officer5,036$8.9911.59%
2/14/2014HASTINGS DAVID CChief Financial Officer34,964$8.99411.34%
2/14/2014FRIEDMAN PAUL ADirector10,227$11.982.45%
2/14/2014FRIEDMAN PAUL ADirector-10,227$65.52-2.39%
2/13/2014Siegel Eric H.EVP, General Counsel27$17.792.27%
2/13/2014Siegel Eric H.EVP, General Counsel3,245$16.66267.30%
2/13/2014Siegel Eric H.EVP, General Counsel4,445$14.7299.69%
2/13/2014Siegel Eric H.EVP, General Counsel2,778$14.0031.20%
2/13/2014Levy Richard SEVP, Chief Drug Dev&Medical Of9,138$11.984.95%
2/13/2014Siegel Eric H.EVP, General Counsel1,389$14.0010.86%
2/13/2014Siegel Eric H.EVP, General Counsel10,390$17.7973.26%
2/13/2014Siegel Eric H.EVP, General Counsel4,802$16.6619.54%
2/13/2014SWAIN PAULA JEVP, Human Resources-216,967$66.73-92.32%
2/13/2014SWAIN PAULA JEVP, Human Resources14,583$13.346.62%
2/13/2014ARIKO BARRY ADirector10,000$7.0221.82%
2/13/2014ARIKO BARRY ADirector-10,000$66.49-17.91%
2/13/2014SWAIN PAULA JEVP, Human Resources16,967$5.4693.94%
2/13/2014SWAIN PAULA JEVP, Human Resources9,665$11.9827.59%
2/13/2014SWAIN PAULA JEVP, Human Resources90,335$11.98202.12%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (INCY), click here.
  • Showing 1-100 of 434 items
  • 1
  • 2
  • 3
  • ...
  • 5
  • >>
Trading Center